Department of EthicsReporting of ethical issues in publications of medical research
Section snippets
Publication of unethical research
Adequate guidance is missing, as to how controversial ethical issues should be addressed. Henry Beecher5 initially exposed unethical conduct in clinical research. He drew an analogy with the US Supreme Court decisions that prohibit the use of criminal evidence obtained by unconstitutional means, and argued that reports with unethical research should not be published in medical journals. A policy prohibiting publication of such research would be a powerful deterrent to the mistreatment of
Scientific methods and ethical considerations
An analogy can be drawn between the rationale for the discussion of scientific methods in published articles, and that of pertinent ethical issues. Medical journals require reports of clinical research to include a methods section, which details study design, techniques of data measurement, and relevant statistical considerations. This requirement helps readers to assess the reliability and validity of the research, and fosters replication of the study. Likewise, research reports should
What ethical issues should be addressed in scientific reports?
Whenever the design of a study has morally controversial features, justification should be provided. Four examples show the range of such study designs. First, in placebo-controlled trials that withhold proven effective treatment, investigators should provide a rationale for the use of placebo.11 An adequate justification would indicate the reasons for placebo as a control, the methodological limitations of an active-controlled trial alternative,12, 13 and the safeguards in place to keep risks
Possible objections
If medical journals insist that investigators address ethical issues, there might be objections. Some might argue that the analogy between the discussion of methodology and that of ethical issues is flawed. Research reports are a form of scientific communication, and a description of study methods allows interpretation of findings and assessment of their scientific value. The description of ethical issues has nothing to do with scientific value and validity. This objection ignores the fact that
Conclusion
In this time of intense concern about the ethics of clinical research, for medical journals to require authors to address pertinent ethical issues would be desirable. Instructions to authors should detail the types of issues to be addressed, and peer reviewers ought to be specifically requested to assess manuscripts with these guidelines. A policy of addressing ethical issues in medical publications has several advantages. First, it encourages serious consideration and discussion of
References (21)
Placebo-controlled trials in psychiatric research: an ethical perspective
Biol Psychiatry
(2000)- et al.
Psychiatric symptom-provoking studies: an ethical appraisal
Biol Psychiatry
(1997) - et al.
A curriculum for teaching psychiatric research bioethics
Biol Psychiatry
(2001) - et al.
US halts Hopkins research
Baltimore Sun
(July 20, 2001) Goodbye to all that. The end of moderate protectionism in human subjects research
Hastings Cent Rep
(2001)- et al.
Addressing ethical issues in the psychiatric research literature
Arch Gen Psychiatry
(1999) - et al.
Disclosure to the reader of institutional review board approval and informed consent
JAMA
(1997) Ethics and clinical research
N Engl J Med
(1966)Editorial responsibility: protecting human rights by restricting publication of unethical research
Cited by (39)
A qualitative analysis of peer recruitment pressures in respondent driven sampling: Are risks above the ethical limit?
2015, International Journal of Drug PolicyCitation Excerpt :This paper qualitatively explores the range of strategies used by a sample of IDUs to recruit peers into an HIV-related study, and the extent to which peer recruiters use certain strategies to exert pressure on their peers to encourage participation. The paper responds to the call by researchers to contribute to developing an evidence-based ethics for RDS through collecting and reporting data on variables related to the process of participant-driven recruitment (Halpern, 2005; Miller & Rosenstein, 2002; Semaan et al., 2009). Data analyzed for this paper were drawn from a mixed-method RDS study funded by the National Institute on Drug Abuse (2011–2014) that systematically examined peer recruitment dynamics and the network structure of a sample of IDUs to test the validity of RDS statistical inference models’ underlying assumption about peer recruitment and social networks.
Tiny tweaks, big changes: An alternative strategy to empower ethical culture of human research in anesthesia (A Taiwan Acta Anesthesiologica Taiwanica-Ethics Review Task Force Report)
2015, Acta Anaesthesiologica TaiwanicaCitation Excerpt :Clinical researchers rarely described or discussed the rationale for ethically controversial features of study design or special procedures instituted to enhance the protection of participants taking part in research, or how to ensure an effective informed consent be obtained. An extensive reporting of pertinent ethical issues in the manuscript to promote public accountability for clinical research has been recommended.73 Recently, inadequate reporting of IRB's review and study participants' informed consent in cluster randomized trials has been concluded and discussed in a series of papers.74–77
Helicobacter pylori eradication therapy research: Ethical issues and description of results
2010, Clinical Gastroenterology and HepatologyCitation Excerpt :Research typically also involves clinically unnecessary procedures and tests specifically designed to assess the safety and outcomes. Research often includes randomization, masking, and the use of placebo, such that neither the physician nor the subject know exactly what was given.6 There are a number of specific ethical issues surrounding human clinical research.
Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling
2009, International Journal of Drug PolicyOral cladribine and fingolimod for relapsing multiple sclerosis [1]
2010, New England Journal of Medicine